These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Segall N, Gawchik S, Georges G, Haeusler JM. Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116 [Abstract] [Full Text] [Related]
3. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B. Clin Exp Allergy; 2003 Mar; 33(3):351-8. PubMed ID: 12614450 [Abstract] [Full Text] [Related]
4. Study of levocetirizine in seasonal allergic rhinitis. Mansfield LE, Hampel F, Haeusler JM, Georges G. Curr Med Res Opin; 2010 Jun; 26(6):1269-75. PubMed ID: 20350147 [Abstract] [Full Text] [Related]
5. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM. Allergy Asthma Proc; 2014 Jun; 35(4):338-45. PubMed ID: 24992553 [Abstract] [Full Text] [Related]
6. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group. Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [Abstract] [Full Text] [Related]
7. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423 [Abstract] [Full Text] [Related]
8. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO. Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145 [Abstract] [Full Text] [Related]
9. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B. Allergy Asthma Proc; 2004 Sep; 25(1):59-68. PubMed ID: 15055564 [Abstract] [Full Text] [Related]
10. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Nathan RA, Finn AF, LaForce C, Ratner P, Chapman D, de Guia EC, Hewlett D, Kramer B. Ann Allergy Asthma Immunol; 2006 Sep; 97(3):389-96. PubMed ID: 17042147 [Abstract] [Full Text] [Related]
12. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group. Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584 [Abstract] [Full Text] [Related]
13. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J. Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719 [Abstract] [Full Text] [Related]
14. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
15. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. Maiti R, Rahman J, Jaida J, Allala U, Palani A. Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756 [Abstract] [Full Text] [Related]
16. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group. J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324 [Abstract] [Full Text] [Related]
17. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A. Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [Abstract] [Full Text] [Related]
18. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis. Fairchild CJ, Meltzer EO, Roland PS, Wells D, Drake M, Wall GM. Allergy Asthma Proc; 2007 Aug; 28(6):716-23. PubMed ID: 18201438 [Abstract] [Full Text] [Related]
19. A randomized, double-blind placebo-controlled study of intranasal standardized cinnamon bark extract for seasonal allergic rhinitis. Steels E, Steels E, Deshpande P, Thakurdesai P, Dighe S, Collet T. Complement Ther Med; 2019 Dec; 47():102198. PubMed ID: 31780001 [Abstract] [Full Text] [Related]
20. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. Day JH, Briscoe MP, Ratz JD. Allergy Asthma Proc; 2008 Dec; 29(3):304-12. PubMed ID: 18387222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]